Nephros Launches the Nephros Water Institute to Lead National Water Safety Education
MWN-AI** Summary
On December 11, 2025, Nephros, Inc. (Nasdaq: NEPH), a leader in point-of-use water filtration, announced the establishment of the Nephros Water Institute. This initiative aims to solidify the company's leadership in water safety education across the nation. Under the guidance of Brianne McGuire, Director of Business Development, Nephros ramped up its educational outreach in 2025, connecting with almost 1,000 professionals through public webinars, speaking engagements, and targeted training programs with healthcare systems.
The Nephros Water Institute will address critical gaps in water safety knowledge, particularly concerning regulatory compliance like ASHRAE 514 and AAMI ST108 standards, as well as emergency preparedness for water contamination events. This educational approach not only enhances water safety standards but has also resulted in increased inquiries and adoption of Nephros's filtration solutions.
Brianne McGuire emphasized the necessity of practical education to tackle inherent risks in potable water, positioning the Institute as a vital resource for leaders in healthcare and related sectors. Robert Banks, President and CEO of Nephros, remarked that the initiative aims to simplify complex water safety information, empowering organizations to make informed decisions about their water systems while expanding customer relationships and supporting long-term growth.
Looking to 2026, Nephros plans to further its educational outreach with a comprehensive schedule of monthly webinars covering topics like Joint Commission accreditation changes, worker safety at sinks, and water quality standards in pharmaceutical compounding. The Nephros Water Institute signifies a commitment to enhancing water safety education as an essential component of the company's mission beyond merely selling filtration products. For more details, visit nephros.com.
MWN-AI** Analysis
Nephros, Inc. (Nasdaq: NEPH) is taking a proactive step in addressing critical gaps in water safety through the launch of the Nephros Water Institute. As a financial analyst, it's essential to delve into how this initiative can impact the company’s market position and potential growth trajectory.
The broader water safety landscape is increasingly scrutinized, with regulatory bodies tightening standards—particularly in sectors like healthcare. Nephros' emphasis on regulatory education and compliance speaks volumes about its commitment to not just sell filtration systems, but to become a thought leader in water safety. By formalizing its educational outreach, Nephros is not only enhancing its credibility but also nurturing vital relationships with healthcare providers who are acutely aware of the risks and responsibilities associated with water quality.
Moreover, the uptick in inbound requests and OEM inquiries indicates that their education initiatives are resonating within the industry. Such engagement can lead to increased sales of their filtration systems, as organizations looking to comply with new regulations will likely turn to established, knowledgeable partners like Nephros. This positions the company favorably for revenue growth, especially as they expand their educational offerings into 2026 and beyond, including monthly webinars that address contemporary concerns such as water quality for pharmaceutical compounding and dialysis purity.
Investors should consider the potential of Nephros stock in the coming months. If the initiative proves effective in driving sales and expanding the customer base, it could lead to a robust upside in the stock price. However, it's also important to remain cautious of the inherent risks associated with forward-looking statements in the company’s communications and the competitive landscape. Monitoring the success of the Nephros Water Institute will be crucial for assessing ongoing investment viability.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
SOUTH ORANGE, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leader in point-of-use water filtration, today announced the launch of the Nephros Water Institute, a dedicated education initiative established to formalize the company’s leadership in industry education.
In 2025, Nephros accelerated its national education efforts under the direction of Brianne McGuire, Director of Business Development. Through high-engagement public webinars, national speaking engagements, and tailored trainings with healthcare systems and consulting partners, Nephros directly reached nearly 1,000 professionals. The regulatory and risk-based educational programming addressed critical blind spots in water safety including ASHRAE 514 compliance, AAMI ST108 sterility standards, and emergency preparedness for compromised water events. These efforts contributed to a marked uptick in inbound requests, OEM inquiries, and programmatic filter adoption.
“Across every sector, we continue to see a fundamental gap in understanding of the risks inherent to potable water,” said Brianne McGuire. “The Nephros Water Institute is our answer to that challenge. By providing the practical education leaders need to ensure safety and readiness, while simultaneously deepening our customer relationships and building the foundation for our long-term growth."
With the formalization of the educational efforts under the Institute, Nephros is establishing a structured, evidence-based curriculum to empower stakeholders responsible for water safety, infection prevention, and regulatory readiness.
“Organizations need clarity, not complexity,” said Robert Banks, President and CEO of Nephros. “The Nephros Water Institute ensures that leaders across healthcare and related sectors have access to accurate, practical information to make safer decisions about their water systems. Our mission extends beyond selling filters; we view education as an essential component of our commitment to water safety and our responsibility to the industry.”
2026 and Beyond
Looking ahead to 2026, Nephros will expand its educational footprint with a full calendar of monthly webinars and product spotlights. Planned content includes:
- Guidance on the reorganized Joint Commission accreditation standards
- Considerations for worker safety at sinks and eyewash stations
- Connecting ICRA and WICRA for water safety during construction
- Water quality for pharmaceutical compounding
- Federal expectations for potable water
- Dialysis water purity
A full list of upcoming events is available on our Events & Speaking Engagements page
About Nephros
Nephros is a leading provider of filtration products to medical and commercial markets, offering a wide range of solutions that deliver superior filtration performance. With advanced hollow-fiber technology and effective commercial filter media, Nephros products help protect against waterborne contaminants, ensuring the highest level of water quality.
For more information about Nephros, visit nephros.com
Forward-Looking Statements
This release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding Nephros’ expected benefits of the Nephros Water Institute and other statements that are not historical facts, including statements that may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business and competitive conditions and regulatory reforms. These and other risks and uncertainties are detailed in Nephros’ reports filed with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2024, which it may update in Part II, Item 1A – Risk Factors in its Quarterly Reports on Form 10-Q that it has filed or will file hereafter. Nephros does not undertake any responsibility to update the forward-looking statements in this release.
Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com
Robert Banks, CEO
Nephros, Inc.
(201) 343-5202
robert.banks@nephros.com
Judy Krandel, CFO
Nephros, Inc.
(201) 343-5202
judy.krandel@nephros.com
FAQ**
How do you envision the Nephros Water Institute enhancing industry standards for water safety, and what specific metrics will you use to measure its impact on customer relationships and filter adoption for Nephros Inc. NEPH?
What strategies will Nephros Inc. NEPH employ to ensure that the educational content provided through the Water Institute aligns with evolving regulatory expectations and industry trends?
Can you elaborate on the role of the Nephros Water Institute in addressing the identified gaps in understanding potable water risks, and how will this initiative differentiate Nephros Inc. NEPH from its competitors?
With plans for expanded educational efforts in 2026, how will Nephros Inc. NEPH prioritize topics to ensure they meet the urgent needs of stakeholders in healthcare and other sectors regarding water safety and compliance?
**MWN-AI FAQ is based on asking OpenAI questions about Nephros Inc. (NASDAQ: NEPH).
NASDAQ: NEPH
NEPH Trading
6.25% G/L:
$4.165 Last:
18,595 Volume:
$4.05 Open:
